Clarus Wealth Advisors Eli Lilly & CO Transaction History

Clarus Wealth Advisors

$196 Million
Q3 2024

A detailed history of Clarus Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Clarus Wealth Advisors holds 733 shares of LLY stock, worth $672,248. This represents 0.33% of its overall portfolio holdings.

Number of Shares

733

Holding current value

$672,248

% of portfolio

0.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$772.14 - $960.02 $565,978 - $703,694	733 New	733 $649,000
Q1 2023 Apr 10, 2023	SELL	$310.63 - $364.82 $224,274 - $263,400	-722 Reduced 54.29%	608 $208,000
Q4 2022 Jan 12, 2023	BUY	$321.55 - $374.67 $964 - $1,124	3 Added 0.23%	1,330 $0
Q3 2022 Oct 11, 2022	SELL	$296.48 - $337.87 $69,672 - $79,399	-235 Reduced 15.04%	1,327 $430,000
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $88,357 - $103,744	-317 Reduced 16.87%	1,562 $517,000
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $16,193 - $20,124	-69 Reduced 3.54%	1,879 $580,000
Q4 2021 Jan 13, 2022	SELL	$224.85 - $279.04 $24,283 - $30,136	-108 Reduced 5.25%	1,948 $538,000
Q3 2021 Oct 06, 2021	BUY	$221.6 - $272.71 $455,609 - $560,691	2,056 New	2,056 $475,000
Q2 2020 Jul 09, 2020	SELL	$136.42 - $164.18 $265,200 - $319,165	-1,944 Closed	0 $0
Q1 2020 Apr 08, 2020	BUY	$119.05 - $147.35 $4,047 - $5,009	34 Added 1.78%	1,944 $271,000
Q4 2019 Jan 10, 2020	SELL	$106.92 - $132.43 $855 - $1,059	-8 Reduced 0.42%	1,910 $260,000
Q3 2019 Oct 11, 2019	SELL	$106.79 - $116.16 $13,562 - $14,752	-127 Reduced 6.21%	1,918 $214,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $187,678 - $219,068	-1,694 Reduced 45.31%	2,045 $227,000
Q1 2019 Apr 04, 2019	BUY	$111.31 - $131.02 $171,862 - $202,294	1,544 Added 70.34%	3,739 $485,000
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $529 - $593	5 Added 0.23%	2,195 $254,000
Q4 2018 Jan 08, 2019	SELL	$105.9 - $118.64 $529 - $593	-5 Reduced 0.23%	2,190 $235,000
Q4 2018 Jan 07, 2019	BUY	$105.9 - $118.64 $529 - $593	5 Added 0.23%	2,195 $254,000
Q3 2018 Oct 03, 2018	BUY	$85.86 - $107.31 $1,030 - $1,287	12 Added 0.55%	2,190 $235,000
Q2 2018 Jul 05, 2018	BUY	$75.7 - $86.88 $164,874 - $189,224	2,178 New	2,178 $169,000

Others Institutions Holding LLY

# of Institutions

3,889

Shares Held

750M

Call Options Held

6.34M

Put Options Held

7.97M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$88.9 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$67.7 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$60.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$47.1 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$31.1 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $871B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Clarus Wealth Advisors with notifications on news.

Account

Clarus Wealth Advisors Eli Lilly & CO Transaction History